title: Thyrotoxic hepatitis.
authors.affiliation: Department of Internal Medicine C, Meir Medical Center, Kfar Saba, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
authors.forename: Liat
authors.initials: L
authors.lastname: Barzilay-Yoseph
authors.forename: Alla
authors.initials: A
authors.lastname: Shabun
authors.forename: Lotan
authors.initials: L
authors.lastname: Shilo
authors.forename: Ruth
authors.initials: R
authors.lastname: Hadary
authors.forename: Dan
authors.initials: D
authors.lastname: Nabriski
authors.forename: Yona
authors.initials: Y
authors.lastname: Kitay-Cohen
mesh_terms: D000328:Adult; D013956:Antithyroid Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006505:Hepatitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D011441:Propylthiouracil / Q000008:administration & dosage / Q000627:therapeutic use*; D013971:Thyrotoxicosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D013956:Antithyroid Agents; D005938:Glucocorticoids; D011441:Propylthiouracil; D011241:Prednisone